A case of adverse drug reaction induced by dispensing error
- PMID: 23084317
- DOI: 10.1016/j.jflm.2012.04.026
A case of adverse drug reaction induced by dispensing error
Abstract
Objective: To report about a case of acute renal failure due to absence of communication between physician and patient.
Case summary: A 78 year old man with human immunodeficiency virus (HIV) accessed our hospital and was brought to our attention in August 2011 for severe renal failure. Clinical history revealed that he had been taking highly active antiretroviral therapy with lamivudine/abacavir and fosamprenavir since 2006. In April 2011 due to an augmentation in creatinine plasma levels, a reduction in lamivudine dosage to 100 mg/day and the prescription of abacavir 300 mg/day became necessary. Unfortunately, the patient took both lamivudine and abacavir therefore the association of the two medications (lamivudine/abacavir) lead to asthenia and acute renal failure within a few days.
Conclusions: This case emphasizes the importance about how physicians must pay very careful attention during drug prescription, most particularly, as far as elderly patients are concerned. In fact, communication improvement between physicians and patients can prevent increase of adverse drug reactions related to drug dispensing, with consequential reduction of costs in the healthcare system.
Copyright © 2012 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.
Similar articles
-
Severe cholestatic hepatitis related to abacavir/lamivudine/dolutegravir antiretroviral treatment in a HIV-1 infected subject.AIDS. 2018 Jul 31;32(12):1727-1729. doi: 10.1097/QAD.0000000000001890. AIDS. 2018. PMID: 30001246 No abstract available.
-
Treatment intensification with abacavir in HIV-infected patients with at least 12 weeks previous lamivudine/zidovudine treatment.Antivir Ther. 2001 Jun;6(2):135-42. Antivir Ther. 2001. PMID: 11491418 Clinical Trial.
-
Response to lamivudine-zidovudine plus abacavir twice daily in antiretroviral-naive, incarcerated patients with HIV infection taking directly observed treatment.Clin Infect Dis. 2002 Feb 15;34(4):511-8. doi: 10.1086/338400. Epub 2002 Jan 4. Clin Infect Dis. 2002. PMID: 11797179 Clinical Trial.
-
Abacavir and lamivudine combination.Expert Opin Drug Metab Toxicol. 2009 Dec;5(12):1599-606. doi: 10.1517/17425250903439720. Expert Opin Drug Metab Toxicol. 2009. PMID: 19929448 Review.
-
Fixed dose combination abacavir/lamivudine in the treatment of HIV-1 infection.Expert Rev Anti Infect Ther. 2005 Dec;3(6):871-83. doi: 10.1586/14787210.3.6.871. Expert Rev Anti Infect Ther. 2005. PMID: 16307500 Review.
Cited by
-
HCV spread among female incarcerated population and treatment pathways to viral elimination in Italian prison settings: clinical perspectives and medico legal aspects.BMC Infect Dis. 2022 Jul 7;22(1):601. doi: 10.1186/s12879-022-07565-2. BMC Infect Dis. 2022. PMID: 35799126 Free PMC article.
-
Data Recorded in Real Life Support the Safety of Nattokinase in Patients with Vascular Diseases.Nutrients. 2021 Jun 13;13(6):2031. doi: 10.3390/nu13062031. Nutrients. 2021. PMID: 34199189 Free PMC article. Clinical Trial.
-
Recurrence of atrial fibrillation after switching from brand to generic atenolol.J Pharmacol Pharmacother. 2015 Jan-Mar;6(1):39-41. doi: 10.4103/0976-500X.149146. J Pharmacol Pharmacother. 2015. PMID: 25709353 Free PMC article.
-
Skin rash during treatment with generic itraconazole.J Pharmacol Pharmacother. 2014 Apr;5(2):158-60. doi: 10.4103/0976-500X.130086. J Pharmacol Pharmacother. 2014. PMID: 24799820 Free PMC article.
-
Pharmacovigilance and drug safety in Calabria (Italy): 2012 adverse events analysis.J Pharmacol Pharmacother. 2013 Dec;4(Suppl 1):S55-60. doi: 10.4103/0976-500X.120963. J Pharmacol Pharmacother. 2013. PMID: 24347984 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
